2-(furan-2-yl)-2-oxo-N-[3-(6-oxo-2-pyrrolidin-1-yl-1H-pyrimidin-4-yl)cyclobutyl]acetamide
C18H20N4O4 — CID 136664836
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(furan-2-yl)-2-oxo-N-[3-(6-oxo-2-pyrrolidin-1-yl-1H-pyrimidin-4-yl)cyclobutyl]acetamide
2-(furan-2-yl)-2-oxo-N-[3-(6-oxo-2-pyrrolidin-1-yl-1H-pyrimidin-4-yl)cyclobutyl]acetamide (PubChem CID 136664836) has the molecular formula C18H20N4O4 and a molecular weight of 356.38 g/mol. Its IUPAC name is 2-(furan-2-yl)-2-oxo-N-[3-(6-oxo-2-pyrrolidin-1-yl-1H-pyrimidin-4-yl)cyclobutyl]acetamide.
Molecular Properties
| Compound Name | 2-(furan-2-yl)-2-oxo-N-[3-(6-oxo-2-pyrrolidin-1-yl-1H-pyrimidin-4-yl)cyclobutyl]acetamide |
|---|---|
| PubChem CID | 136664836 |
| Molecular Formula | C18H20N4O4 |
| Molecular Weight | 356.38 g/mol |
| Exact Mass | 356.15 |
| IUPAC Name | 2-(furan-2-yl)-2-oxo-N-[3-(6-oxo-2-pyrrolidin-1-yl-1H-pyrimidin-4-yl)cyclobutyl]acetamide |
| SMILES | O=C(NC1CC(c2cc(=O)[nH]c(N3CCCC3)n2)C1)C(=O)c1ccco1 |
| InChI | InChI=1S/C18H20N4O4/c23-15-10-13(20-18(21-15)22-5-1-2-6-22)11-8-12(9-11)19-17(25)16(24)14-4-3-7-26-14/h3-4,7,10-12H,1-2,5-6,8-9H2,(H,19,25)(H,20,21,23) |
| InChIKey | GJQJZULVSGBASO-UHFFFAOYSA-N |
| XLogP | 1.21 |
| TPSA | 108.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 356.38 |
| LogP ≤ 5 | 1.21 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136664836 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.